| Authors: |
Remiszewski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska- Curie National Research Institute of Oncology, Warsaw, Poland.; Medical Faculty, Medical University of Warsaw, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Tysarowski A; Cancer Molecular and Genetic Diagnostics Laboratory, Maria Sklodowska- Curie National Research Institute of Oncology, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Seliga KA; Cancer Molecular and Genetic Diagnostics Laboratory, Maria Sklodowska- Curie National Research Institute of Oncology, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Bobak K; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska- Curie National Research Institute of Oncology, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Piątkowski J; Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Golik P; Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Spałek MJ; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska- Curie National Research Institute of Oncology, Warsaw, Poland.; Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Szumera-Ciećkiewicz A; Department of Radiotherapy I, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Department of Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Wągrodzki M; Department of Radiotherapy I, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska- Curie National Research Institute of Oncology, Warsaw, Poland.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska- Curie National Research Institute of Oncology, Warsaw, Poland. anna.czarnecka@gmail.com.; Diagnostic Hematology Department, Institute of Hematology and Transfusion Medicine, Warsaw, Poland. anna.czarnecka@gmail.com.; Department of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland. anna.czarnecka@gmail.com.; Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. anna.czarnecka@gmail.com. |
